20 results
DEFM14A
APGN
Apexigen Inc
30 Jun 23
Proxy related to merger
4:21pm
of Apexigen’s third-party manufacturer to procure raw materials from third-party suppliers and potential exposure to supply chain issues impacting … manufacturing and bioresearch monitoring facilities, and drug product manufacturing and supply chain inspections. Recently, President Biden announced
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:03pm
suppliers and potential exposure to supply chain issues impacting delivery dates, quality, quantity and pricing of raw materials, including due … and bioresearch monitoring facilities, and drug product manufacturing and supply chain inspections. Recently, President Biden announced that the administration
424B3
APGN
Apexigen Inc
10 Apr 23
Prospectus supplement
4:02pm
of our third-party manufacturer to procure raw materials from third-party suppliers and potential exposure to supply chain issues impacting delivery … , remote interactive evaluations of drug manufacturing and bioresearch monitoring facilities, and drug product manufacturing and supply chain inspections
POS AM
rgwp5iunt ij7btxoh
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
6kz8g
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
424B3
1y73q
9 Sep 22
Prospectus supplement
4:40pm
424B3
7snurhp
9 Sep 22
Prospectus supplement
4:38pm
424B3
gistdg4 cm
6 Jul 22
Prospectus supplement
4:18pm
S-4/A
wdsycnqqqil 7v87
23 May 22
Registration of securities issued in business combination transactions (amended)
8:00pm
S-4
9ove776 9m6xaqhlh
8 Apr 22
Registration of securities issued in business combination transactions
6:37pm
- Prev
- 1
- Next